Patent details

Basic Information

Publication number:

92612

Type:

SPC

SPC Type:

Medical

Basic Patent Number:

EP001194968

Legal Status:

Lapsed

Application number:

92612

First applicant's nationality:

Procedural language:

French

Marketing Authorization

Marketing Authorization Number:

EU/1/07/414/001-017 Galvus-vildagliptin

Marketing Authorization Type:

Marketing Authorization Date:

28/09/2007

Marketing Authorization Status:

Accepted

Marketing Authorization Country:

Dates

Filing date:

15/12/2014

First Marketing Authorization date:

28/09/2007

Grant date:

21/10/2015

Activation date:

24/04/2017

Publication date:

21/10/2015

Lapsed date:

24/04/2021

Expiration date:

Renunciation date:

Revocation date:

Annulment date:

Basic SPC Expiration:

24/04/2022

SPC Extension Expiration:

24/04/2022

Rejection date:

Withdrawal date:

Owner

From:

15/12/2014

 

 

Name:

Royalty Pharma Collection Trust

Address:

Rodney Square North 1100 North Market Street, Wilmington DE 19890, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/12/2014

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Pauly Robert P., Dr., Walter McKenzie Centre

Address:

Canada (CA)

2

Name:

Demuth Hans-Ulrich

Address:

Germany (DE)

3

Name:

Schmidt Jörn

Address:

Germany (DE)

4

Name:

McIntosh Christopher H.S.

Address:

Canada (CA)

5

Name:

Pederson Ray A.

Address:

Canada (CA)

6

Name:

Rosche Fred

Address:

Germany (DE)

Publication

Bulletin

Bulletin Heading:

SPC3

Bulletin edition number:

2017/02

Publication date:

22/06/2017

Description:

Section E : Supplementary Protection certificates entered into force – IA publication

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

30/04/2020

Last Annual Fee Paid Number:

24

Last Annual Fee Paid Amount:

440 Euro

Payer:

OFFICE FREYLINGER S.A.

Filing date	Document type	Number of pages